Get started
Author

Andreas Kallsoy Slættanes

Observed names: Andreas K Slættanes, Andreas Kallsoy Slaettanes, Andreas Slættanes
Observed institution: ALK-Abelló (Denmark)
ORCID: 0009-0007-6749-1536
Observed ORCID: 0009-0007-6749-1536
OpenAlex ID: A5029257247
Long‐Term, Real‐World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma
2025 · Christian Woehlk, Thomas Stranzl, et al. · Allergy · 14
PDF
Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions
2025 · Gunter Sturm, Maria Beatrice Bilò, et al. · Allergy · 4
PDF
A Cost-Utility Analysis of SQ® Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
2023 · Richard F Pollock, Andreas K Slættanes, et al. · ClinicoEconomics and Outcomes Research · 4
PDF
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden
2024 · Lars-Olaf Cardell, Thomas Sterner, et al. · Scientific Reports · 3
PDF
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
2024 · Lars-Olaf Cardell, Thomas Sterner, et al. · ClinicoEconomics and Outcomes Research · 1
PDF
Correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
2024 · Celeste Porsbjerg, Benedikt Fritzsching, et al. · Allergy
PDF
Works count: 6
Citation count: 26
H-index: 3
I10-index: 1
Year
Topic
Type